667 related articles for article (PubMed ID: 31256694)
41. Treatment Approaches to Mycobacterium abscessus Pulmonary Disease.
Holt MR; Baird T
Clin Chest Med; 2023 Dec; 44(4):785-798. PubMed ID: 37890916
[TBL] [Abstract][Full Text] [Related]
42. Nontuberculous mycobacterial pulmonary diseases in immunocompetent patients.
Koh WJ; Kwon OJ; Lee KS
Korean J Radiol; 2002; 3(3):145-57. PubMed ID: 12271159
[TBL] [Abstract][Full Text] [Related]
43. Cumulative antimicrobial susceptibilities for respiratory clinical isolates of
Shakoor S; Shafiq S; Shahid A; Mir F; Ali R; Hasan R
Int J Mycobacteriol; 2023; 12(3):310-315. PubMed ID: 37721238
[TBL] [Abstract][Full Text] [Related]
44. Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.
Prasla Z; Sutliff RL; Sadikot RT
Am J Respir Cell Mol Biol; 2020 Aug; 63(2):144-151. PubMed ID: 32160017
[TBL] [Abstract][Full Text] [Related]
45. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
Izumi K; Morimoto K; Hasegawa N; Uchimura K; Kawatsu L; Ato M; Mitarai S
Ann Am Thorac Soc; 2019 Mar; 16(3):341-347. PubMed ID: 30339468
[TBL] [Abstract][Full Text] [Related]
46. Host-Directed Therapy in Nontuberculous Mycobacterial Pulmonary Disease: Preclinical and Clinical Data Review.
Anidi IU; Olivier KN
Clin Chest Med; 2023 Dec; 44(4):839-845. PubMed ID: 37890920
[TBL] [Abstract][Full Text] [Related]
47. Clinical Characteristics and Treatment Outcomes of Pulmonary Diseases Caused by Coinfections With Multiple Nontuberculous Mycobacterial Species.
Kim S; Woo A; Yong SH; Leem AY; Lee SH; Lee SH; Kim SY; Chung K; Kim EY; Jung JY; Kang YA; Park MS; Kim YS; Park Y
J Korean Med Sci; 2024 May; 39(20):e167. PubMed ID: 38804011
[TBL] [Abstract][Full Text] [Related]
48.
Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
[TBL] [Abstract][Full Text] [Related]
49. Distribution of nontuberculous mycobacteria in treated patients with pulmonary disease in Greece - relation to microbiological data.
Manika K; Tsikrika S; Tsaroucha E; Karabela S; Karachaliou I; Bosmi I; Kioumis I; Papavasileiou A
Future Microbiol; 2015; 10(8):1301-6. PubMed ID: 26226382
[TBL] [Abstract][Full Text] [Related]
50. Efflux Pump Inhibitors Against Nontuberculous Mycobacteria.
Rindi L
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545436
[TBL] [Abstract][Full Text] [Related]
51.
Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
[TBL] [Abstract][Full Text] [Related]
52. New insights in the treatment of nontuberculous mycobacterial pulmonary disease.
Ruth MM; van Ingen J
Future Microbiol; 2017 Oct; 12():1109-1112. PubMed ID: 28972416
[No Abstract] [Full Text] [Related]
53. Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study.
Henriette Zweijpfenning SM; Chiron R; Essink S; Schildkraut J; Akkerman OW; Aliberti S; Altenburg J; Arets B; van Braeckel E; Delaere B; Gohy S; Haarman E; Lorent N; McKew G; Morgan L; Wagner D; van Ingen J; Hoefsloot W
Chest; 2022 Jul; 162(1):76-81. PubMed ID: 35063454
[No Abstract] [Full Text] [Related]
54. Epidemiology of pulmonary disease due to nontuberculous mycobacteria in Southern China, 2013-2016.
Tan Y; Su B; Shu W; Cai X; Kuang S; Kuang H; Liu J; Pang Y
BMC Pulm Med; 2018 Nov; 18(1):168. PubMed ID: 30413193
[TBL] [Abstract][Full Text] [Related]
55. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections.
Kendall BA; Winthrop KL
Semin Respir Crit Care Med; 2013 Feb; 34(1):87-94. PubMed ID: 23460008
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives.
Larsson LO; Polverino E; Hoefsloot W; Codecasa LR; Diel R; Jenkins SG; Loebinger MR
Expert Rev Respir Med; 2017 Dec; 11(12):977-989. PubMed ID: 28967797
[TBL] [Abstract][Full Text] [Related]
57. Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs.
Gu Y; Nie W; Huang H; Yu X
Front Cell Infect Microbiol; 2023; 13():1243457. PubMed ID: 37850054
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
[TBL] [Abstract][Full Text] [Related]
59. Medical Management of Pulmonary Nontuberculous Mycobacterial Disease.
Philley JV; Griffith DE
Thorac Surg Clin; 2019 Feb; 29(1):65-76. PubMed ID: 30454923
[TBL] [Abstract][Full Text] [Related]
60. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD010004. PubMed ID: 32521055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
